Lataa...
Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
BACKGROUND: Immune checkpoint inhibitors targeting the programmed cell death‐1 (PD‐1)/PD‐1 ligand 1 (PD‐L1) axis have shown promising results in patients with nonsmall cell lung cancer (NSCLC). One major PD‐L1 inducer is IFNγ, which is secreted by T cells and NK cells. Importantly, IFNγ‐induced PD‐L...
Tallennettuna:
| Julkaisussa: | Thorac Cancer |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons Australia, Ltd
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7952785/ https://ncbi.nlm.nih.gov/pubmed/33491334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13847 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|